Agilon Health Deadline Approaches: AGL Investors Have Opportunity to Lead Securities Fraud Lawsuit

Agilon Health investors have until March 2, 2026, to seek lead plaintiff status in a securities class action lawsuit filed by Rosen Law Firm. The lawsuit alleges that defendants made false or misleading statements and/or failed to disclose material industry headwinds and the immediate positive financial impact from "strategic actions" taken by Agilon. Investors who purchased securities during the class period may be entitled to compensation without payment of fees or costs through a contingency fee arrangement.